AdvanSix [ASIX] vs Asp Isotopes [ASPI] Detailed Stock Comparison
AdvanSix
NYSE
Loading...
Asp Isotopes
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: AdvanSix wins in 12 metrics, Asp Isotopes wins in 6 metrics, with 0 ties. AdvanSix appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | AdvanSix | Asp Isotopes | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 6.35 | -15.52 | Asp Isotopes |
| Price-to-Book Ratio | 0.59 | 16.47 | AdvanSix |
| Debt-to-Equity Ratio | 45.86 | 84.08 | AdvanSix |
| PEG Ratio | 4.47 | -64.80 | Asp Isotopes |
| EV/EBITDA | 5.19 | -26.48 | Asp Isotopes |
| Profit Margin (TTM) | 5.10% | 38.60% | Asp Isotopes |
| Operating Margin (TTM) | 8.12% | -721.89% | AdvanSix |
| EBITDA Margin (TTM) | 8.12% | N/A | N/A |
| Return on Equity | 9.85% | -115.46% | AdvanSix |
| Return on Assets (TTM) | 3.44% | -26.14% | AdvanSix |
| Free Cash Flow (TTM) | $1.69M | $-28.07M | AdvanSix |
| Dividend Yield | 2.02% | N/A | N/A |
| 1-Year Return | -34.91% | 356.37% | Asp Isotopes |
| Price-to-Sales Ratio (TTM) | 0.32 | 201.67 | AdvanSix |
| Enterprise Value | $843.31M | $740.82M | AdvanSix |
| EV/Revenue Ratio | 0.56 | 168.16 | AdvanSix |
| Gross Profit Margin (TTM) | 14.32% | 29.67% | Asp Isotopes |
| Revenue per Share (TTM) | $56 | $0 | AdvanSix |
| Earnings per Share (Diluted) | $2.84 | $-0.59 | AdvanSix |
| Beta (Stock Volatility) | 1.60 | 3.39 | AdvanSix |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
AdvanSix vs Asp Isotopes Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| AdvanSix | -1.41% | -5.58% | -27.14% | -22.13% | -38.47% | -34.47% |
| Asp Isotopes | -3.72% | 4.37% | 31.64% | 60.69% | 47.94% | 88.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| AdvanSix | -34.91% | -54.76% | 30.36% | -5.63% | -5.63% | -5.63% |
| Asp Isotopes | 356.37% | 232.50% | 232.50% | 232.50% | 232.50% | 232.50% |
Performance & Financial Health Analysis: AdvanSix vs Asp Isotopes
| Metric | ASIX | ASPI |
|---|---|---|
| Market Information | ||
| Market Cap | $484.00M | $888.46M |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 255,520 | 3,789,974 |
| 90 Day Avg. Volume | 227,663 | 4,297,911 |
| Last Close | $18.13 | $9.32 |
| 52 Week Range | $17.99 - $33.00 | $1.95 - $10.82 |
| % from 52W High | -45.06% | -13.86% |
| All-Time High | $57.10 (Mar 14, 2022) | $10.82 (Jul 25, 2025) |
| % from All-Time High | -68.25% | -13.86% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.10% | 0.31% |
| Quarterly Earnings Growth | -0.19% | 0.31% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.39% |
| Operating Margin (TTM) | 0.08% | -7.22% |
| Return on Equity (TTM) | 0.10% | -1.15% |
| Debt to Equity (MRQ) | 45.86 | 84.08 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $30.69 | $0.59 |
| Cash per Share (MRQ) | $0.69 | $0.75 |
| Operating Cash Flow (TTM) | $153.97M | $-16,894,872 |
| Levered Free Cash Flow (TTM) | $-2,640,250 | $-20,013,620 |
| Dividends | ||
| Last 12-Month Dividend Yield | 2.02% | N/A |
| Last 12-Month Dividend | $0.48 | N/A |
Valuation & Enterprise Metrics Analysis: AdvanSix vs Asp Isotopes
| Metric | ASIX | ASPI |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 6.35 | -15.52 |
| Forward P/E | 4.47 | -64.80 |
| PEG Ratio | 4.47 | -64.80 |
| Price to Sales (TTM) | 0.32 | 201.67 |
| Price to Book (MRQ) | 0.59 | 16.47 |
| Market Capitalization | ||
| Market Capitalization | $484.00M | $888.46M |
| Enterprise Value | $843.31M | $740.82M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.56 | 168.16 |
| Enterprise to EBITDA | 5.19 | -26.48 |
| Risk & Other Metrics | ||
| Beta | 1.60 | 3.39 |
| Book Value per Share (MRQ) | $30.69 | $0.59 |
Financial Statements Comparison: AdvanSix vs Asp Isotopes
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | ASIX | ASPI |
|---|---|---|
| Revenue/Sales | $377.79M | $1.10M |
| Cost of Goods Sold | $324.32M | $774,765 |
| Gross Profit | $53.47M | $326,840 |
| Research & Development | N/A | $1.53M |
| Operating Income (EBIT) | $30.06M | $-7.95M |
| EBITDA | $49.65M | $-8.23M |
| Pre-Tax Income | $28.93M | $-8.53M |
| Income Tax | $5.59M | $-70,720 |
| Net Income (Profit) | $23.34M | $-8.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | ASIX | ASPI |
|---|---|---|
| Cash & Equivalents | $8.34M | $55.97M |
| Total Current Assets | $418.18M | $59.03M |
| Total Current Liabilities | $350.95M | $8.18M |
| Long-Term Debt | $320.44M | $36.96M |
| Total Shareholders Equity | $794.37M | $45.73M |
| Retained Earnings | $650.44M | $-64.62M |
| Property, Plant & Equipment | $1.07B | $1.02M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | ASIX | ASPI |
|---|---|---|
| Operating Cash Flow | $15.06M | $-7.16M |
| Capital Expenditures | N/A | $-2.36M |
| Free Cash Flow | $-22.62M | $-5.53M |
| Debt Repayment | $-98.75M | $-262,304 |
| Common Stock Repurchase | $-1.49M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | ASIX | ASPI |
|---|---|---|
| Shares Short | 501,716 | 16.34M |
| Short Ratio | 2.64 | 4.67 |
| Short % of Float | 0.02% | 0.24% |
| Average Daily Volume (10 Day) | 255,520 | 3,789,974 |
| Average Daily Volume (90 Day) | 227,663 | 4,297,911 |
| Shares Outstanding | 26.74M | 72.07M |
| Float Shares | 26.00M | 54.53M |
| % Held by Insiders | 0.03% | 0.23% |
| % Held by Institutions | 0.91% | 0.36% |
Dividend Analysis & Yield Comparison: AdvanSix vs Asp Isotopes
| Metric | ASIX | ASPI |
|---|---|---|
| Last 12-Month Dividend | $0.48 | N/A |
| Last 12-Month Dividend Yield | 2.02% | N/A |
| 3-Year Avg Annual Dividend | $0.51 | N/A |
| 3-Year Avg Dividend Yield | 0.51% | N/A |
| 3-Year Total Dividends | $1.52 | N/A |
| Ex-Dividend Date | Mar 10, 2025 | N/A |